← Leaderboards
Kandice Ann Kapinos
Rand Corporation
$461,356
Attributed
$729,615
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $389.3K · FY2020–21$500K$375K$250K$125K$0
'20
'21
Funding mix
By agency
NIH$729,615 · 2
By mechanism
R21$536,518 · 1
R03$193,097 · 1
Top collaborators
- Jonathan Cantor2 shared
Most similar at Rand Corporation
Same institution · by research overlap
- Darius N. Lakdawalla$3,586,901
- Pinar Karaca-Mandic$4,055,014
Others in their field
Other Emerging Leaders on “Cost”
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
- Scott Topper · Broad Institute, Inc.$77,958,806
- Yunda Huang · Fred Hutchinson Cancer Center$51,342,169
- Mark Marino · Venturewell$48,913,644
- John Damon Chodera · Sloan-Kettering Inst Can Research$48,367,817
- Leonard Freedman · Leidos Biomedical Research, Inc.$41,527,040
Research focus
CostMedicarePoliciesBaseAdultElderlyHealth Care CostsPaymentAffectCaringAddictionCenters Of Research ExcellenceCharacteristicsChargeDefensive MedicineAgedAccident And Emergency DepartmentData SetData LinkagesCountyBeneficiaryDeath RateComplexAward
Grant awards (4)
Substance Use and Access to Care among Older Adults$243,083
R21 · FY2021 · AG · contact PI
Using Sovereign Immunity to Examine the Effects of Tort Liability on Defensive Medicine and Health$97,187
R03 · FY2021 · AG · contact PI
Substance Use and Access to Care among Older Adults$293,435
R21 · FY2020 · AG · contact PI
Using Sovereign Immunity to Examine the Effects of Tort Liability on Defensive Medicine and Health$95,910
R03 · FY2020 · AG · contact PI